Ambassador of Pakistan Saima Sayed on Wednesday said that Pakistan viewed Senegal as a key player in West Africa and a major ...

MIAMI, Jan. 29, 2025 /PRNewswire/ -- Global private investment firm, Bridgewest Group, recognized for developing innovative ...

West Pharmaceutical Services Inc. closed 20.09% short of its 52-week high of $413.56, which the company reached on February ...

The abstract, Phase 1 Dose-Escalation Study of Next-Generation Nectin-4 Targeting Antibody-Drug Conjugate CRB-701 (SYS6002) in US And UK Patients with Urothelial Cancer and other Solid Tumors ( Perez, ...

The stock's rise snapped a three-day losing streak.

West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are presently covering the firm, Ratings ...

West Pharmaceutical Services has a 12 month low of $265.00 and a 12 month high of $413.70. The firm has a fifty day simple moving average of $332.25 and a 200-day simple moving average of $314.42.

West Pharmaceutical Services, Inc. WST is well poised for growth, backed by the robust Proprietary Products segment and sustained strength in research and development (R&D). However, foreign ...

Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...

KODATEF is not approved for use in the U.S. Demand for ARAKODA has been steadily growing in recent months as awareness and use of the product has expanded across the U.S. The Company is taking the ...

Looking at the universe of stocks we cover at Dividend Channel, on 2/7/25, West Pharmaceutical Services, Inc. (Symbol: WST), SouthState Corp (Symbol: SSB), and Pinnacle Financial Partners Inc ...